GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (MEX:WST) » Definitions » Shiller PE Ratio

West Pharmaceutical Services (MEX:WST) Shiller PE Ratio : 62.58 (As of Sep. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is West Pharmaceutical Services Shiller PE Ratio?

As of today (2024-09-25), West Pharmaceutical Services's current share price is MXN5969.08. West Pharmaceutical Services's E10 for the quarter that ended in Jun. 2024 was MXN95.39. West Pharmaceutical Services's Shiller PE Ratio for today is 62.58.

The historical rank and industry rank for West Pharmaceutical Services's Shiller PE Ratio or its related term are showing as below:

MEX:WST' s Shiller PE Ratio Range Over the Past 10 Years
Min: 35.72   Med: 67.76   Max: 165.26
Current: 60.03

During the past years, West Pharmaceutical Services's highest Shiller PE Ratio was 165.26. The lowest was 35.72. And the median was 67.76.

MEX:WST's Shiller PE Ratio is ranked worse than
80.59% of 273 companies
in the Medical Devices & Instruments industry
Industry Median: 25.29 vs MEX:WST: 60.03

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

West Pharmaceutical Services's adjusted earnings per share data for the three months ended in Jun. 2024 was MXN27.663. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is MXN95.39 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


West Pharmaceutical Services Shiller PE Ratio Historical Data

The historical data trend for West Pharmaceutical Services's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Shiller PE Ratio Chart

West Pharmaceutical Services Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.84 122.41 144.14 57.23 72.61

West Pharmaceutical Services Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 84.75 79.46 72.61 78.44 63.84

Competitive Comparison of West Pharmaceutical Services's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


West Pharmaceutical Services's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where West Pharmaceutical Services's Shiller PE Ratio falls into.



West Pharmaceutical Services Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

West Pharmaceutical Services's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=5969.08/95.39
=62.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

West Pharmaceutical Services's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, West Pharmaceutical Services's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=27.663/132.5538*132.5538
=27.663

Current CPI (Jun. 2024) = 132.5538.

West Pharmaceutical Services Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 5.774 100.428 7.621
201412 6.342 99.070 8.486
201503 6.860 99.621 9.128
201506 5.962 100.684 7.849
201509 0.338 100.392 0.446
201512 7.738 99.792 10.278
201603 5.164 100.470 6.813
201606 11.096 101.688 14.464
201609 9.668 101.861 12.581
201612 10.721 101.863 13.951
201703 15.251 102.862 19.653
201706 9.219 103.349 11.824
201709 12.159 104.136 15.477
201712 0.000 104.011 0.000
201803 10.537 105.290 13.266
201806 14.737 106.317 18.374
201809 13.655 106.507 16.994
201812 13.548 105.998 16.942
201903 14.161 107.251 17.502
201906 16.904 108.070 20.734
201909 14.807 108.329 18.118
201912 15.842 108.420 19.368
202003 23.214 108.902 28.256
202006 27.929 108.767 34.037
202009 24.079 109.815 29.065
202012 25.661 109.897 30.951
202103 40.678 111.754 48.249
202106 49.168 114.631 56.855
202109 47.498 115.734 54.401
202112 39.592 117.630 44.615
202203 45.596 121.301 49.826
202206 49.893 125.017 52.901
202209 31.983 125.227 33.854
202212 26.515 125.222 28.068
202303 33.346 127.348 34.709
202306 35.316 128.729 36.365
202309 37.276 129.860 38.049
202312 31.063 129.419 31.815
202403 25.724 131.776 25.876
202406 27.663 132.554 27.663

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


West Pharmaceutical Services  (MEX:WST) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


West Pharmaceutical Services Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


West Pharmaceutical Services Business Description

Traded in Other Exchanges
Address
530 Herman O. West Drive, Exton, PA, USA, 19341-0645
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.